CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542,781 | -31.1% | 24,864 | -23.0% | 0.00% | -66.7% |
| Q1 2023 | $787,797 | -53.6% | 32,300 | -40.0% | 0.00% | -57.1% |
| Q4 2022 | $1,696,978 | -17.2% | 53,804 | -25.8% | 0.01% | -30.0% |
| Q3 2022 | $2,050,000 | +523.1% | 72,544 | +671.5% | 0.01% | +900.0% |
| Q1 2022 | $329,000 | +11.1% | 9,403 | +2.9% | 0.00% | 0.0% |
| Q4 2021 | $296,000 | -86.7% | 9,139 | -87.9% | 0.00% | -83.3% |
| Q3 2021 | $2,224,000 | – | 75,387 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |